HARD 发表于 2025-3-30 12:02:47

Heat-Shock-Protein-Based Vaccines against Cancers and Intracellular Infectionsnactivated cancer cells are immune to subsequent challenges of live cancer cells. The phenomenon was shown to be individually tumor-specific, in that mice were immune specifically to the tumors that were used to immunize them and not to other tumors (Basombrio 1970; Globerson and Feldman 1964), hence the nomenclature . tumor rejection antigens.

RALES 发表于 2025-3-30 12:48:56

Characterization of Antigens Recognized by T Cells on Human Tumors involved in tumor rejection, can be cultured in vitro and used as tools to identify the target antigens expressed by the tumor cells (Boon et al. 1994). Tumor-specific CTLs have been found in most mouse tumor models, and in several human tumor types, mainly in melanoma. By using a genetic approach

毕业典礼 发表于 2025-3-30 20:22:58

Shared and Individual CTL-Defined Antigens on Human Melanoma Cells intact proteins, but protein-derived peptides presented by HLA molecules on the cell surface. HLA-associated peptides originate from proteins of any cellular location. This allows T cells to survey the organism for any alteration occurring intracellularly and opens up an enormous variety of potenti

责怪 发表于 2025-3-30 21:17:33

http://reply.papertrans.cn/89/8841/884037/884037_54.png

节约 发表于 2025-3-31 02:15:41

http://reply.papertrans.cn/89/8841/884037/884037_55.png

CRUMB 发表于 2025-3-31 08:20:49

http://reply.papertrans.cn/89/8841/884037/884037_56.png

旅行路线 发表于 2025-3-31 10:11:15

http://reply.papertrans.cn/89/8841/884037/884037_57.png

碌碌之人 发表于 2025-3-31 15:00:15

Towards the Development of Immunogenic Colon Cancer Cells for Immunotherapyed to be the result of either a failure to induce resting pre-effector T lymphocytes to differentiate into effector cells or active mechanisms of immunosuppression which are exerted by tumor cells as soluble inhibitory activities. One must expect that both mechanisms play a role in the interaction b
页: 1 2 3 4 5 [6]
查看完整版本: Titlebook: Symposium in Immunology VI; Tumor Immunology Martha M. Eibl,Christoph Huber,Ulrich Wahn Conference proceedings 1997 Springer-Verlag Berlin